{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:30:49Z","timestamp":1770107449813,"version":"3.49.0"},"reference-count":185,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/bib\/bbx045","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T18:03:53Z","timestamp":1490983433000},"source":"Crossref","is-referenced-by-count":60,"title":["In silico polypharmacology of natural products"],"prefix":"10.1093","author":[{"given":"Jiansong","family":"Fang","sequence":"first","affiliation":[]},{"given":"Chuang","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Ping","family":"Lin","sequence":"additional","affiliation":[]},{"given":"Feixiong","family":"Cheng","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"key":"key\n\t\t\t\t20170428004205_bbx045-B1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B2","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1039\/C4NP00064A","article-title":"Natural product and natural product derived drugs in clinical trials","volume":"31","year":"2014","journal-title":"Nat Prod Rep"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B3","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cell.2015.11.031","article-title":"A new golden age of natural products drug discovery","volume":"163","year":"2015","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrc3017","article-title":"Molecular targets of phytochemicals for cancer prevention","volume":"11","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1517\/17425255.2014.950222","article-title":"Drug-target interaction prediction via chemogenomic space: learning-based methods","volume":"10","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B7","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery","volume":"57","year":"2014","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B8","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","year":"2013","journal-title":"Science"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1172\/JCI68339","article-title":"The next steps in next-gen sequencing of cancer genomes","volume":"125","year":"2015","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B10","doi-asserted-by":"crossref","first-page":"S63.","DOI":"10.1038\/537S63a","article-title":"Perspective: the precision-oncology illusion","volume":"537","year":"2016","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/clpt.2013.40","article-title":"Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan?","volume":"93","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pharmthera.2016.02.004","article-title":"Effect of Liuwei Dihuang decoction, a traditional Chinese medicinal prescription, on the neuroendocrine immunomodulation network","volume":"162","year":"2016","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/psp4.12172","article-title":"Systems pharmacology-based discovery of natural products for precision oncology through targeting cancer mutated genes","volume":"6","year":"2017","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","year":"2015","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B16","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature02627","article-title":"Oncogenomics and the development of new cancer therapies","volume":"429","year":"2004","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrclinonc.2013.244","article-title":"Rapid learning for precision oncology","volume":"11","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B19","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.semcancer.2015.02.007","article-title":"Cancer prevention and therapy through the modulation of the tumor microenvironment","volume":"35","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00109-015-1376-x","article-title":"Immunosuppressive cells in tumor immune escape and metastasis","volume":"94","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B21","doi-asserted-by":"crossref","first-page":"52517","DOI":"10.18632\/oncotarget.9593","article-title":"Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B22","doi-asserted-by":"crossref","first-page":"655.","DOI":"10.3389\/fpls.2015.00655","article-title":"Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials","volume":"6","year":"2015","journal-title":"Front Plant Sci"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B23","doi-asserted-by":"crossref","first-page":"13017","DOI":"10.1007\/s13277-016-5183-y","article-title":"Molecular targets of curcumin for cancer therapy: an updated review","volume":"37","year":"2016","journal-title":"Tumour Biol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/092986710790149738","article-title":"Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications","volume":"17","year":"2010","journal-title":"Curr Med Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B25","first-page":"641","article-title":"Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression","volume":"1","year":"2008","journal-title":"Mol Med Rep"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(00)02089-5","article-title":"Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells","volume":"483","year":"2000","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B27","first-page":"243","article-title":"Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation","volume":"480\u2013481","year":"2001","journal-title":"Mutat Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/mt.2015.165","article-title":"Curcumin micelles remodel tumor microenvironment and enhance vaccine activity in an advanced melanoma model","volume":"24","year":"2016","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B29","article-title":"Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review","journal-title":"Crit Rev Food Sci Nutr"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B30","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1021\/jf903377e","article-title":"Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells","volume":"58","year":"2010","journal-title":"J Agric Food Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B32","doi-asserted-by":"crossref","first-page":"28370","DOI":"10.1074\/jbc.M802200200","article-title":"(-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase","volume":"283","year":"2008","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B33","doi-asserted-by":"crossref","first-page":"529.","DOI":"10.3390\/nu8090529","article-title":"Molecular targets underlying the anticancer effects of quercetin: an update","volume":"8","year":"2016","journal-title":"Nutrients"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B34","doi-asserted-by":"crossref","first-page":"45489","DOI":"10.18632\/oncotarget.9993","article-title":"Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B35","doi-asserted-by":"crossref","first-page":"e47516.","DOI":"10.1371\/journal.pone.0047516","article-title":"Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT\/mTOR\/P70S6K signaling pathways","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B36","doi-asserted-by":"crossref","first-page":"12927","DOI":"10.1007\/s13277-016-5184-x","article-title":"Molecular mechanisms of action of quercetin in cancer: recent advances","volume":"37","year":"2016","journal-title":"Tumour Biol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jneuroim.2008.09.008","article-title":"Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients","volume":"205","year":"2008","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B38","first-page":"45673","article-title":"Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages","volume":"2007","year":"2007","journal-title":"Mediators Inflamm"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B39","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/jn\/137.5.1208","article-title":"Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells","volume":"137","year":"2007","journal-title":"J Nutr"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.intimp.2015.12.008","article-title":"The immunostimulating activity of quercetin 3-O-xyloside in murine macrophages via activation of the ASK1\/MAPK\/NF-kappaB signaling pathway","volume":"31","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","article-title":"Cancer chemopreventive activity of resveratrol, a natural product derived from grapes","volume":"275","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B42","first-page":"8.","article-title":"Anticancer molecular mechanisms of resveratrol","volume":"3","year":"2016","journal-title":"Front Nutr"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.intimp.2014.07.004","article-title":"Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages","volume":"22","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.intimp.2016.01.028","article-title":"The enhancement of immune function and activation of NF-kappaB by resveratrol-treatment in immunosuppressive mice","volume":"33","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/13543776.2016.1118060","article-title":"Pharmacological effects of berberine and its derivatives: a patent update","volume":"26","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejphar.2014.06.025","article-title":"Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer","volume":"740","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jep.2015.10.028","article-title":"Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives","volume":"176","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B48","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/1535-7163.MCT-05-0448","article-title":"Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells","volume":"5","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B49","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1038\/onc.2010.379","article-title":"Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition","volume":"29","year":"2010","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B50","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.18632\/oncotarget.6407","article-title":"Melatonin inhibits AP-2beta\/hTERT, NF-kappaB\/COX-2 and Akt\/ERK and activates caspase\/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2009.01.033","article-title":"Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9","volume":"279","year":"2009","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/0976-0105.103820","article-title":"Inflammation, macrophage in cancer progression and chinese herbal treatment","volume":"3","year":"2012","journal-title":"J Basic Clin Pharm"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B53","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The essential medicinal chemistry of curcumin","volume":"60","year":"2017","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B54","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/acs.jmedchem.6b01507","article-title":"Drug repurposing of histone deacetylase inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 hydrolase and blocking LTB4 biosynthesis","volume":"60","year":"2017","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B55","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1039\/C4NP00068D","article-title":"Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review","volume":"31","year":"2014","journal-title":"Nat Prod Rep"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B56","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1039\/C5NP00005J","article-title":"Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products","volume":"32","year":"2015","journal-title":"Nat Prod Rep"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B57","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nbt1338","article-title":"Drug-target network","volume":"25","year":"2007","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B58","first-page":"1070","article-title":"Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database","volume":"17","year":"2016","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B59","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: an update","volume":"42","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B60","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B61","doi-asserted-by":"crossref","first-page":"D255","DOI":"10.1093\/nar\/gkp965","article-title":"An overview of the PubChem BioAssay resource","volume":"38","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B62","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B63","doi-asserted-by":"crossref","first-page":"D1069","DOI":"10.1093\/nar\/gkv1230","article-title":"Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information","volume":"44","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B64","doi-asserted-by":"crossref","first-page":"D1036","DOI":"10.1093\/nar\/gkv1165","article-title":"DGIdb 2.0: mining clinically relevant drug-gene interactions","volume":"44","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B65","doi-asserted-by":"crossref","first-page":"D401","DOI":"10.1093\/nar\/gkt1207","article-title":"STITCH 4: integration of protein-chemical interactions with user data","volume":"42","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B66","doi-asserted-by":"crossref","first-page":"W26","DOI":"10.1093\/nar\/gku477","article-title":"SuperPred: update on drug classification and target prediction","volume":"42","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B67","doi-asserted-by":"crossref","first-page":"D1055","DOI":"10.1093\/nar\/gkq1165","article-title":"HIT: linking herbal active ingredients to targets","volume":"39","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B68","doi-asserted-by":"crossref","first-page":"D1089","DOI":"10.1093\/nar\/gks1100","article-title":"TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis","volume":"41","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B69","doi-asserted-by":"crossref","first-page":"13.","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","year":"2014","journal-title":"J Cheminform"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B70","doi-asserted-by":"crossref","first-page":"D1124","DOI":"10.1093\/nar\/gks1047","article-title":"NPACT: naturally occurring plant-based anti-cancer compound-activity-target database","volume":"41","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B71","doi-asserted-by":"crossref","first-page":"11481.","DOI":"10.1038\/srep11481","article-title":"CancerHSP: anticancer herbs database of systems pharmacology","volume":"5","year":"2015","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B72","doi-asserted-by":"crossref","first-page":"D1228","DOI":"10.1093\/nar\/gks1147","article-title":"InnateDB: systems biology of innate immunity and beyond\u2013recent updates and continuing curation","volume":"41","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cellimm.2007.01.012","article-title":"Immunome: a reference set of genes and proteins for systems biology of the human immune system","volume":"244","year":"2006","journal-title":"Cell Immunol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B74","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.gene.6364173","article-title":"Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data","volume":"6","year":"2005","journal-title":"Genes Immun"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B75","doi-asserted-by":"crossref","first-page":"7.","DOI":"10.1186\/1471-2172-9-7","article-title":"The Innate Immune Database (IIDB)","volume":"9","year":"2008","journal-title":"BMC Immunol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B76","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/ni1008-1091","article-title":"The Immunological Genome Project: networks of gene expression in immune cells","volume":"9","year":"2008","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B77","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrc2044","article-title":"The connectivity map: a new tool for biomedical research","volume":"7","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B78","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gku476","article-title":"LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures","volume":"42","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B79","doi-asserted-by":"crossref","first-page":"D921","DOI":"10.1093\/nar\/gku955","article-title":"Open TG-GATEs: a large-scale toxicogenomics database","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B80","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2217\/14622416.7.7.1025","article-title":"Toxicogenomics in drug discovery and development: mechanistic analysis of compound\/class-dependent effects using the DrugMatrix database","volume":"7","year":"2006","journal-title":"Pharmacogenomics"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B81","doi-asserted-by":"crossref","first-page":"D470","DOI":"10.1093\/nar\/gku1204","article-title":"The BioGRID interaction database: 2015 update","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B82","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","article-title":"Human protein reference database\u20132009 update","volume":"37","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nmeth.2289","article-title":"Interactome3D: adding structural details to protein networks","volume":"10","year":"2013","journal-title":"Nat Methods"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B84","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B85","doi-asserted-by":"crossref","first-page":"D857","DOI":"10.1093\/nar\/gkr930","article-title":"MINT, the molecular interaction database: 2012 update","volume":"40","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B86","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nm.2323","article-title":"Cancer genomics: from discovery science to personalized medicine","volume":"17","year":"2011","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B87","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature08987","article-title":"International network of cancer genome projects","volume":"464","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B88","first-page":"pl1.","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","year":"2013","journal-title":"Sci Signal"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B89","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world's knowledge of somatic mutations in human cancer","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B90","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrg1317","article-title":"Chemogenomics: an emerging strategy for rapid target and drug discovery","volume":"5","year":"2004","journal-title":"Nat Rev Genet"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B91","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B92","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1038\/527S108a","article-title":"Genetics: big hopes for big data","volume":"527","year":"2015","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B93","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.18632\/oncotarget.1984","article-title":"Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy","volume":"5","year":"2014","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B94","doi-asserted-by":"crossref","first-page":"e1004497.","DOI":"10.1371\/journal.pcbi.1004497","article-title":"A gene gravity model for the evolution of cancer genomes: a study of 3,000 cancer genomes across 9 cancer types","volume":"11","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B95","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2217\/bmm.15.81","article-title":"Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science","volume":"9","year":"2015","journal-title":"Biomark Med"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B96","doi-asserted-by":"crossref","first-page":"e1005074.","DOI":"10.1371\/journal.pcbi.1005074","article-title":"Systems biology-based investigation of cellular antiviral drug targets identified by gene-trap insertional mutagenesis","volume":"12","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B97","first-page":"65.","article-title":"Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach","volume":"10 (Suppl 3)","year":"2016","journal-title":"BMC Syst Biol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B98","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10549-016-4011-9","article-title":"Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CA H1047R in HER2\/ER-positive breast cancer","volume":"160","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B99","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/molbev\/msu167","article-title":"Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome","volume":"31","year":"2014","journal-title":"Mol Biol Evol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B100","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/bib\/bbv068","article-title":"Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes","volume":"17","year":"2016","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B101","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1038\/onc.2015.90","article-title":"Cancer whole-genome sequencing: present and future","volume":"34","year":"2015","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B102","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug-target interaction prediction: databases, web servers and computational models","volume":"17","year":"2016","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B103","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jprot.2011.05.011","article-title":"From in silico target prediction to multi-target drug design: current databases, methods and applications","volume":"74","year":"2011","journal-title":"J Proteomics"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B104","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.2174\/092986712801661068","article-title":"Approaches to target profiling of natural products","volume":"19","year":"2012","journal-title":"Curr Med Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B105","first-page":"413","article-title":"In silico target fishing: predicting biological targets from chemical structure","volume":"3","year":"2007","journal-title":"Drug Discov Today Technol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B106","doi-asserted-by":"crossref","first-page":"e1293.","DOI":"10.1038\/cddis.2014.250","article-title":"Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening","volume":"5","year":"2014","journal-title":"Cell Death Dis"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B107","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1039\/C6CC01079B","article-title":"Structure-based screening and optimization of cytisine derivatives as inhibitors of the menin-MLL interaction","volume":"52","year":"2016","journal-title":"Chem Commun"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B108","doi-asserted-by":"crossref","first-page":"21268","DOI":"10.18632\/oncotarget.4178","article-title":"Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor","volume":"6","year":"2015","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B109","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1021\/np100935s","article-title":"Inverse virtual screening of antitumor targets: pilot study on a small database of natural bioactive compounds","volume":"74","year":"2011","journal-title":"J Nat Prod"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B110","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10822-014-9748-9","article-title":"Design, synthesis and experimental validation of novel potential chemopreventive agents using random forest and support vector machine binary classifiers","volume":"28","year":"2014","journal-title":"J Comput Aided Mol Des"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B111","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.neo.2015.08.009","article-title":"Identification of a selective G1-phase benzimidazolone inhibitor by a senescence-targeted virtual screen using artificial neural networks","volume":"17","year":"2015","journal-title":"Neoplasia"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B112","doi-asserted-by":"crossref","first-page":"i232","DOI":"10.1093\/bioinformatics\/btn162","article-title":"Prediction of drug-target interaction networks from the integration of chemical and genomic spaces","volume":"24","year":"2008","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B113","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/bioinformatics\/btp433","article-title":"Supervised prediction of drug-target interactions using bipartite local models","volume":"25","year":"2009","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B114","first-page":"219","article-title":"Prediction of compound-target interactions of natural products using large-scale drug and protein information","volume":"17 (Suppl 6)","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B115","doi-asserted-by":"crossref","first-page":"e37608.","DOI":"10.1371\/journal.pone.0037608","article-title":"A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B116","doi-asserted-by":"crossref","first-page":"e1002503.","DOI":"10.1371\/journal.pcbi.1002503","article-title":"Prediction of drug-target interactions and drug repositioning via network-based inference","volume":"8","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B117","doi-asserted-by":"crossref","first-page":"e41064.","DOI":"10.1371\/journal.pone.0041064","article-title":"Prediction of chemical-protein interactions network with weighted network-based inference method","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B118","first-page":"333","article-title":"SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning","volume":"18","year":"2017","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B119","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1111\/bph.13629","article-title":"In silico prediction of chemical mechanism of action via an improved network-based inference method","volume":"173","year":"2016","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2006.09.005","article-title":"Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators","volume":"10","year":"2006","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B121","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","article-title":"Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance","volume":"10","year":"2006","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B122","doi-asserted-by":"crossref","first-page":"1255784.","DOI":"10.1126\/science.1255784","article-title":"Tracking cancer drugs in living cells by thermal profiling of the proteome","volume":"346","year":"2014","journal-title":"Science"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B123","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nmeth.3652","article-title":"Thermal proteome profiling monitors ligand interactions with cellular membrane proteins","volume":"12","year":"2015","journal-title":"Nat Methods"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B124","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cels.2016.02.005","article-title":"Deep proteomics of breast cancer cells reveals that metformin rewires signaling networks away from a pro-growth state","volume":"2","year":"2016","journal-title":"Cell Syst"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B125","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1074\/jbc.M111.288894","article-title":"Exometabolome analysis identifies pyruvate dehydrogenase as a target for the antibiotic triphenylbismuthdichloride in multiresistant bacterial pathogens","volume":"287","year":"2012","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B126","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1021\/bi200113y","article-title":"A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling","volume":"50","year":"2011","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B127","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.bcp.2010.07.007","article-title":"Biochemical disorders induced by cytotoxic marine natural products in breast cancer cells as revealed by proton NMR spectroscopy-based metabolomics","volume":"80","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B128","volume-title":"Structure-based Drug Discovery","year":"2007"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.chembiol.2011.12.007","article-title":"Established and emerging trends in computational drug discovery in the structural genomics era","volume":"19","year":"2012","journal-title":"Chem Biol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B130","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.2174\/1568026616666160530181149","article-title":"Molecular docking for identification of potential targets for drug repurposing","volume":"16","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B131","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.2174\/1568026616666160530181328","article-title":"Drug repositioning through network pharmacology","volume":"16","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B132","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1080\/14728222.2016.1192131","article-title":"Structures of androgen receptor bound with ligands: advancing understanding of biological functions and drug discovery","volume":"20","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B133","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.biochi.2012.06.004","article-title":"Discovery of a natural product inhibitor targeting protein neddylation by structure-based virtual screening","volume":"94","year":"2012","journal-title":"Biochimie"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B134","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1039\/b926359d","article-title":"Identification of natural product fonsecin B as a stabilizing ligand of c-myc G-quadruplex DNA by high-throughput virtual screening","volume":"46","year":"2010","journal-title":"Chem Commun"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B135","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1039\/C1SC00152C","article-title":"Molecular docking for virtual screening of natural product databases","volume":"2","year":"2011","journal-title":"Chem Sci"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B136","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4155\/fmc.13.214","article-title":"Challenges and opportunities in targeting the menin-MLL interaction","volume":"6","year":"2014","journal-title":"Future Med Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B137","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G","article-title":"Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule","volume":"43","year":"2001","journal-title":"Proteins"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B138","doi-asserted-by":"crossref","first-page":"W393","DOI":"10.1093\/nar\/gks496","article-title":"idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach","volume":"40","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B139","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1016\/j.bmc.2012.03.072","article-title":"Inverse virtual screening allows the discovery of the biological activity of natural compounds","volume":"20","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B140","doi-asserted-by":"crossref","first-page":"81.","DOI":"10.1186\/s13073-014-0081-7","article-title":"Functional consequences of somatic mutations in cancer using protein pocket-based prioritization approach","volume":"6","year":"2014","journal-title":"Genome Med"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B141","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1074\/mcp.M115.053199","article-title":"Systematic prioritization of druggable mutations in approximately 5000 genomes across 16 cancer types using a structural genomics-based approach","volume":"15","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B142","doi-asserted-by":"crossref","first-page":"8114.","DOI":"10.1038\/srep08114","article-title":"FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach","volume":"5","year":"2015","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B143","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","year":"2014","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B144","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.drudis.2014.10.012","article-title":"Machine-learning approaches in drug discovery: methods and applications","volume":"20","year":"2015","journal-title":"Drug Discov Today"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B145","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2174\/1389450116666151102095555","article-title":"Chemical structure similarity search for ligand-based virtual screening: methods and computational resources","volume":"17","year":"2016","journal-title":"Curr Drug Targets"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B146","doi-asserted-by":"crossref","first-page":"W609","DOI":"10.1093\/nar\/gkq300","article-title":"PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach","volume":"38","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B147","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1021\/ci300601q","article-title":"Enhancing molecular shape comparison by weighted Gaussian functions","volume":"53","year":"2013","journal-title":"J Chem Inf Model"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B148","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1021\/ci400331p","article-title":"Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery","volume":"53","year":"2013","journal-title":"J Chem Inf Model"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B149","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11030-014-9561-3","article-title":"Consensus models for CDK5 inhibitors in silico and their application to inhibitor discovery","volume":"19","year":"2015","journal-title":"Mol Divers"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/ci500574n","article-title":"Discovery of multitarget-directed ligands against Alzheimer's disease through systematic prediction of chemical-protein interactions","volume":"55","year":"2015","journal-title":"J Chem Inf Model"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B151","doi-asserted-by":"crossref","first-page":"9857.","DOI":"10.1039\/C5RA23035G","article-title":"Discovery of neuroprotective compounds by machine learning approaches","volume":"6","year":"2016","journal-title":"RSC Adv"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B152","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2174\/15680266113139990033","article-title":"In silico ADMET prediction: recent advances, current challenges and future trends","volume":"13","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B153","doi-asserted-by":"crossref","first-page":"i221","DOI":"10.1093\/bioinformatics\/btv256","article-title":"Improving compound-protein interaction prediction by building up highly credible negative samples","volume":"31","year":"2015","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B154","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-62703-107-3_9","article-title":"Chemogenomic approaches to infer drug-target interaction networks","volume":"939","year":"2013","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B155","doi-asserted-by":"crossref","first-page":"e11764.","DOI":"10.1371\/journal.pone.0011764","article-title":"Network-based relating pharmacological and genomic spaces for drug target identification","volume":"5","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B156","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/bib\/bbt035","article-title":"Systems pharmacology in drug discovery and therapeutic insight for herbal medicines","volume":"15","year":"2014","journal-title":"Brief Bioinform"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B157","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/minf.201400066","article-title":"Benchmarking a wide range of chemical descriptors for drug-target interaction prediction using a chemogenomic approach","volume":"33","year":"2014","journal-title":"Mol Inform"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B158","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1039\/c2mb25110h","article-title":"Prediction of chemical-protein interactions: multitarget-QSAR versus computational chemogenomic methods","volume":"8","year":"2012","journal-title":"Mol Biosyst"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B159","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1039\/c3mb25309k","article-title":"Prediction of human genes and diseases targeted by xenobiotics using predictive toxicogenomic-derived models (PTDMs)","volume":"9","year":"2013","journal-title":"Mol Biosyst"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B160","doi-asserted-by":"crossref","first-page":"5576.","DOI":"10.1038\/srep05576","article-title":"Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology","volume":"4","year":"2014","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B161","doi-asserted-by":"crossref","first-page":"45584","DOI":"10.18632\/oncotarget.10052","article-title":"Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B162","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1069492","article-title":"Systems biology: a brief overview","volume":"295","year":"2002","journal-title":"Science"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B163","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature01254","article-title":"Computational systems biology","volume":"420","year":"2002","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B164","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drudis.2013.10.003","article-title":"Systems biology in drug discovery and development","volume":"19","year":"2014","journal-title":"Drug Discov Today"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B165","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.molmed.2016.09.006","article-title":"Drug repurposing: new treatments for Zika virus infection?","volume":"22","year":"2016","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B166","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.drudis.2012.07.017","article-title":"Applications of connectivity map in drug discovery and development","volume":"17","year":"2012","journal-title":"Drug Discov Today"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B167","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/cvr\/cvs346","article-title":"Proteomics: from single molecules to biological pathways","volume":"97","year":"2013","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B168","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-biochem-072909-100424","article-title":"Mass spectrometry-based proteomics and network biology","volume":"81","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B169","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/nprot.2015.101","article-title":"Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry","volume":"10","year":"2015","journal-title":"Nat Protoc"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B170","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.pharmtox.48.113006.094715","article-title":"Metabolomics: a global biochemical approach to drug response and disease","volume":"48","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B171","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.drudis.2015.11.014","article-title":"Identifying targets for antibiotic development using omics technologies","volume":"21","year":"2016","journal-title":"Drug Discov Today"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B172","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cmet.2015.04.009","article-title":"SoNar, a highly responsive NAD+\/NADH sensor, allows high-throughput metabolic screening of anti-tumor agents","volume":"21","year":"2015","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B173","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1055\/s-0030-1249898","article-title":"Metabolomics: a tool for anticancer lead-finding from natural products","volume":"76","year":"2010","journal-title":"Planta Med"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B174","doi-asserted-by":"crossref","first-page":"40.","DOI":"10.1186\/1471-2288-14-40","article-title":"External validation of multivariable prediction models: a systematic review of methodological conduct and reporting","volume":"14","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B175","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.trecan.2016.06.001","article-title":"Gender dimorphism creates divergent cancer susceptibilities","volume":"2","year":"2016","journal-title":"Trends Cancer"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B176","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jamia\/ocw007","article-title":"A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes","volume":"23","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B177","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nbt.2345","article-title":"Navigating cancer network attractors for tumor-specific therapy","volume":"30","year":"2012","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B178","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev-genet-120213-092314","article-title":"Cancer: evolution within a lifetime","volume":"48","year":"2014","journal-title":"Annu Rev Genet"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B179","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.semcancer.2013.06.001","article-title":"Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance","volume":"23","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B180","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B181","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1158\/0008-5472.CAN-12-3232","article-title":"Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures","volume":"72","year":"2012","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B182","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pharmthera.2015.12.006","article-title":"Microtubule-stabilizing agents: new drug discovery and cancer therapy","volume":"162","year":"2016","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B183","first-page":"77","article-title":"Autoimmune cardiotoxicity of cancer immunotherapy","volume":"38","year":"2016","journal-title":"Trends Immunol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B184","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","article-title":"The future of cancer treatment: immunomodulation, CARs and combination immunotherapy","volume":"13","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"key\n\t\t\t\t20170428004205_bbx045-B185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/cts.12391","article-title":"Immunotherapy and novel combinations in oncology: current landscape, challenges, and opportunities","volume":"9","year":"2016","journal-title":"Clin Transl Sci"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/doi\/10.1093\/bib\/bbx045\/14009822\/bbx045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T03:15:12Z","timestamp":1658891712000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article-lookup\/doi\/10.1093\/bib\/bbx045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":185,"URL":"https:\/\/doi.org\/10.1093\/bib\/bbx045","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}